Affiliation:
1. Department of Women's and Children's Health Uppsala University Uppsala Sweden
2. Department of Pediatric Oncology Uppsala University Hospital Uppsala Sweden
3. Department of Special Education Stockholm University Stockholm Sweden
4. Department of Women's and Children's Health Karolinska Institutet Stockholm Sweden
Abstract
AbstractBackgroundMany children treated for cancer experience a negative impact on their academic performance; however, most studies of children treated for sarcomas have not investigated academic performance. Our aim was to explore how Swedish children treated for sarcomas perform academically, as well as how they adjust to life afterwards.ProcedureWe compared 167 pediatric sarcoma survivors with 776 matched, non‐sibling controls without a history of cancer, in a retrospective cohort study using data from nationwide registries. Primary outcomes were grades at the end of compulsory education, high school eligibility, post‐compulsory education (i.e., education after school Year 9), employment, and sickness or activity compensation.ResultsPediatric sarcoma survivors were more likely to be ineligible for high school (odds ratio [OR] 1.76; p = .045) and more likely to fail Swedish (OR 2.12; p = .046), mathematics (OR 2.27; p = .011), and/or physical education (OR 2.24; p = .004), compared with controls. Survivors were less likely to have been employed (OR 0.58; p = .027) and received sickness or activity compensation more often (OR 2.49; p = .008) compared with controls.ConclusionsPediatric sarcoma survivors have poorer academic performance compared to peers without cancer in multiple school subjects. Survivors seem to catch up during post‐compulsory education, but might struggle to find employment.
Subject
Oncology,Hematology,Pediatrics, Perinatology and Child Health
Reference41 articles.
1. HowladerN NooneA KrapchoM et al.SEER cancer statistics review 1975–2017.National Cancer Institute. Accessed May 2 2023.https://seer.cancer.gov/csr/1975_2017/index.html
2. Ewing sarcoma